MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis
Citations Over TimeTop 10% of 2015 papers
Abstract
Although different autoimmune diseases show discrete clinical features, there are common molecular pathways intimately involved. Here we show that miR-125a is downregulated in peripheral CD4(+) T cells of human autoimmune diseases including systemic lupus erythematosus and Crohn's disease, and relevant autoimmune mouse models. miR-125a stabilizes both the commitment and immunoregulatory capacity of Treg cells. In miR-125a-deficient mice, the balance appears to shift from immune suppression to inflammation, and results in more severe pathogenesis of colitis and experimental autoimmune encephalomyelitis (EAE). The genome-wide target analysis reveals that miR-125a suppresses several effector T-cell factors including Stat3, Ifng and Il13. Using a chemically synthesized miR-125a analogue, we show potential to re-programme the immune homeostasis in EAE models. These findings point to miR-125a as a critical factor that controls autoimmune diseases by stabilizing Treg-mediated immune homeostasis.
Related Papers
- → Autoimmunity and Heavy Metals(1994)85 cited
- → Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus.(2003)78 cited
- → Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?(2000)52 cited
- From autoimmunity to autoimmune disease(2012)
- → Autoimmunity(2010)